Dengue Cost of Illness Studies: Status Report Presented at: Spring Meeting of Board of Counselors Donald S. Shepard, Ph.D.* Jose Suaya, M.D., Ph.D.* Mariana Caram, M.A.* Site colleagues *Program Management Team, Dengue Burden Studies
Related searches for Dengue Cost of Illness Studies: Status Report
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Spring Meeting of Board of Counselors
Donald S. Shepard, Ph.D.*
Jose Suaya, M.D., Ph.D.*
Mariana Caram, M.A.*
*Program Management Team, Dengue Burden Studies
Schneider Institute for Health Policy, Heller School, MS 035
Brandeis University, Waltham, MA 02454-9110 USA
Tel: 781-736-3975 • Fax: 781-736-3928
E-mail: [email protected]
April 25-26, 2006, Seoul, Korea
2001 – Ho Chi Minh City, Vietnam stakeholder dengue meeting included economic topics.
2002 – Burden of Illness (BOI) included in PDVI’s grant application to Gates Foundation and countries invited to submit concept papers.
2003 – PDVI issued a Request for Proposals for the BOI Program Management Team (PMT) and selected Brandeis University
2004 – PMT recommended and PDVI approved and funded studies in 8 countries.
2005 – Data collection started.
2006 – Data are being cleaned and analyzed. Reports of results and international workshops are being planned.
Total cost of a resource = Quantity x Unit cost
Hospitalization cost = length of stay x cost per day
Cost of lost time = days lost x value per day
Number of Participants(as of 4/20/06)
Studies were designed to follow current laboratory test practices at study sites, so our samples and costs are representative of the current laboratory capacity in the countries studied.
Tests were performed at national or regional reference laboratories.
Depending on the timing and number of blood samples, laboratories performed serology tests, viral isolation, and/or PCR.
Fraction of patients receiving serology tests varied with care patterns in the countries.
In six countries, all patients tested.
In three countries, about half tested.
Serology: Gates Foundation Question
* Data collected by Prof. Lucy Lum from 654 dengue hospitalizations in 2 public and 2 private hospitals around Kuala Lumpur in 2003.